ATE91304T1 - Verfahren zur herstellung des pres 1/s2/shepatitis-b-antigens aus hefe. - Google Patents

Verfahren zur herstellung des pres 1/s2/shepatitis-b-antigens aus hefe.

Info

Publication number
ATE91304T1
ATE91304T1 AT88301382T AT88301382T ATE91304T1 AT E91304 T1 ATE91304 T1 AT E91304T1 AT 88301382 T AT88301382 T AT 88301382T AT 88301382 T AT88301382 T AT 88301382T AT E91304 T1 ATE91304 T1 AT E91304T1
Authority
AT
Austria
Prior art keywords
antigen
yeast
shepatitis
pres
procedure
Prior art date
Application number
AT88301382T
Other languages
English (en)
Inventor
Shigeko Yamazaki
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE91304T1 publication Critical patent/ATE91304T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AT88301382T 1987-02-27 1988-02-18 Verfahren zur herstellung des pres 1/s2/shepatitis-b-antigens aus hefe. ATE91304T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1982087A 1987-02-27 1987-02-27
EP88301382A EP0280470B1 (de) 1987-02-27 1988-02-18 Verfahren zur Herstellung des pres 1/S2/S-Hepatitis-B-Antigens aus Hefe

Publications (1)

Publication Number Publication Date
ATE91304T1 true ATE91304T1 (de) 1993-07-15

Family

ID=21795203

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88301382T ATE91304T1 (de) 1987-02-27 1988-02-18 Verfahren zur herstellung des pres 1/s2/shepatitis-b-antigens aus hefe.

Country Status (5)

Country Link
EP (1) EP0280470B1 (de)
JP (1) JPS63270628A (de)
AT (1) ATE91304T1 (de)
DE (1) DE3882154T2 (de)
DK (1) DK100888A (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3883596T2 (de) * 1987-03-09 1994-02-17 Merck & Co Inc Reinigung von rekombiniertem Hepatitis-B-Oberflächen-Antigen.
US5011915A (en) * 1987-10-26 1991-04-30 Merck & Co., Inc. Process for purifying recombinant hepatitis antigens
EP0314240A3 (de) * 1987-10-26 1990-03-28 Merck & Co. Inc. Verfahren für de Reinigung von rekombinanten Hepatitis-Antigenen
EP0328123A1 (de) * 1988-02-09 1989-08-16 Eugene Tech International, Inc. Pre-S-reiches Hepatitis-B-Oberflächenantigen
IL99025A0 (en) * 1990-08-15 1992-07-15 Astra Ab Novel process for the detection of pathogens using dna probes
CU22290A1 (es) * 1990-10-08 1995-01-31 Cigb Procedimiento para la obtencion de antigeno de superficie del virus de la hepatitis b de superior capacidad inmunoganica y su uso en un preparado vacunal
US5102989A (en) * 1991-03-15 1992-04-07 Merck & Co., Inc. Method of stabilizing recombinant hepatitis B virus surface proteins from recombinant host cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR76274B (de) * 1981-08-04 1984-08-04 Univ California
KR850001534A (ko) * 1983-08-22 1985-03-30 제임스 에프. 나우톤 형질전환된 효모로 부터 유도된 면역원성 HBsAg
US4649192A (en) * 1985-05-30 1987-03-10 Smith Kline-Rit Method for the isolation and purification of hepatitis B surface antigen using polysorbate
EP0232410A4 (de) * 1985-08-15 1988-01-25 Amgen Spaltverfahren und puffer zur extraktion von hepatitis-b-oberflächenantigen aus hefezellen.
US4895800A (en) * 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen

Also Published As

Publication number Publication date
EP0280470B1 (de) 1993-07-07
JPS63270628A (ja) 1988-11-08
EP0280470A1 (de) 1988-08-31
DE3882154T2 (de) 1993-12-02
DK100888D0 (da) 1988-02-26
DE3882154D1 (de) 1993-08-12
DK100888A (da) 1988-10-28

Similar Documents

Publication Publication Date Title
DE68929115T2 (de) Verfahren zur Herstellung von menschlichem Serumalbumin in Hefe
FI101381B1 (fi) Nukleotidisekvenssi ja menetelmä polypeptidin HSA(1-387) tuottamiseksi
ATE170630T1 (de) Proteine mit geänderten epitopen und verfahren zur deren herstellung
DE69210645D1 (de) Verfahren zur Herstellung von cysteinfreien Peptiden
DE69110663D1 (de) Verfahren zur herstellung eines enzymhydrolysates.
ATE123780T1 (de) Verfahren zur verwendung und herstellung von peptiden.
ATE68826T1 (de) Verfahren zur herstellung von reifem, menschlichem serum-albumin.
NO872988L (no) Pattedyr-interleukin-4.
DE69031791D1 (de) Verfahren zur HCV-Züchtung in Zell-Linien aus B- oder T-Lymphozyten
ATE73298T1 (de) Verfahren zum erhalt von konzentraten aus molke, die einen hohen alpha-lactalbumingehalt haben.
ATE138923T1 (de) Verfahren zur herstellung gereinigter glycolipide durch membrantrennverfahren
DE69011880T2 (de) Verfahren zur Herstellung von L-Aminosäuren durch Fermentation.
ATE166881T1 (de) Verfahren zur herstellung von faktor viii
ATE91304T1 (de) Verfahren zur herstellung des pres 1/s2/shepatitis-b-antigens aus hefe.
ATE131490T1 (de) Verfahren zur herstellung von gereinigten albuminlösungen
DE3574269D1 (en) Apparatus for the separation of products from a product-substrate mixture
AT384032B (de) Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag)
KR890008166A (ko) 융합 단백질의 선택적 분해 방법
ES2041690T3 (es) Metodo para la purificacion de anticuerpos.
DK628188A (da) Protein og fremgangsmaade til fremstilling deraf
ATE110112T1 (de) Verfahren und systeme zur herstellung von hiv- antigenen.
ATE91303T1 (de) Verfahren zur herstellung von peptiden durch spezifische spaltung von gentechnisch gewonnenen fusionsproteinen mit collagenasen.
FI950960A (fi) Peptidialkoholien kiinteän faasin synteesi

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee